查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1494809

到 2030 年心血管和軟組織修復貼片市場預測：按產品類型、材料類型、應用、最終用戶和地區進行的全球分析

Cardiovascular & Soft Tissue Repair Patch Market Forecasts to 2030 - Global Analysis By Product Type, Material Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2024 年全球心血管和軟組織修復補片市場規模將達到 50 億美元，預計在預測期內將以 10.1% 的複合年成長率成長，到 2030 年達到 90 億美元。

心血管和軟組織修復補片是外科手術中用於修復心血管系統受損或衰弱組織或體內軟組織的醫療設備。這些貼片通常由與人體自然癒合過程相容的生物相容性材料製成，例如合成聚合物或生物組織。在心血管手術中，這些補片通常用於修復心臟壁缺陷，例如間隔缺陷或先天性心臟缺陷，或增強血管薄弱區域，例如動脈瘤或動脈切開術。

根據PubMed Central 2021 年8 月發表的一篇論文，對沙烏地阿拉伯的500 名參與者進行了一項橫斷面研究，腹部疝氣的盛行率為38.8%，18-25 歲參與者中的盛行率為21.2%。

心血管疾病和軟組織損傷的盛行率上升

由於老化、生活方式改變和遺傳傾向等因素，包括心臟病和先天性心臟疾病在內的心血管疾病變得越來越常見，增加了對有效手術介入的需求。同樣，由於體力活動增加和創傷等因素，疝氣和腹壁缺損等軟組織損傷的發生率也在增加。此類需要手術修復的疾病的激增正在推動對高級修復補丁的需求。這些補片為加強或替換受損組織、提高手術效果和患者康復以及推動市場成長提供了可靠的解決方案。

手術費用上升

由於開發和製造過程中涉及先進的材料和技術，先進的醫療設備通常需要大量成本。因此，使用這些貼片進行手術的總費用可能會讓許多患者望而卻步，尤其是那些保險不足或醫療資金有限的地區的患者。因此，與這些手術相關的經濟挑戰阻礙了心血管和軟組織修復補片市場的廣泛採用和成長。

材料科學與技術的進展

生物工程組織、合成聚合物和奈米材料等生物相容性材料的創新促進了更有效、更耐用和多功能修復貼片的開發。這些尖端材料提高了貼片與自然組織融合的能力，降低了排斥風險並增強了整體癒合過程。此外，技術的進步使得能夠創建具有特殊功能的貼片，例如藥物釋放型特性，可以將藥物直接輸送到修復部位以防止感染並促進癒合，從而使心血管和軟組織修復貼片成為可能，這導致了越來越普及。

嚴格的監管要求

FDA 和 EMA 等監管機構對安全性、有效性和品質制定了嚴格的標準，並要求進行廣泛的臨床測試和記錄。這導致製造商的開發時間更長，成本更高。製造商必須投入大量資源來滿足這些嚴格的標準。因此，嚴格的監管要求可能會限制新的和改進的心血管和軟組織修復補片的供應，阻礙市場成長並延遲患者獲得最先進治療。

COVID-19 的影響

最初，針對 COVID-19 病例的封鎖和資源分配導致選擇性手術減少，包括那些需要修復修補程式的手術。結果，市場成長暫時下降。然而，隨著醫療保健系統的調整，手術恢復，市場復甦。對衛生的關注也可能鼓勵了無菌貼片的採用。總體而言，在暫時的挫折之後，在心血管疾病盛行率上升和貼片技術進步的推動下，市場預計將恢復到疫情前的成長軌跡。

預計心臟補片細分市場在預測期內將是最大的

由於心臟補片常用於微創心血管手術，預計心臟補片在預測期內將達到最大值。這種微創方法是心血管治療的主要趨勢，而心臟貼片在促進這一過程中發揮重要作用。隨著微創手術普及，對心臟貼片的需求預計將會增加。此外，有效的心臟補片可以促進組織再生、改善心臟功能並減少併發症。這可以改善患者的治療效果，從而提高外科醫生的採用率，並增加對這些貼片的需求。

血管修復與重組領域預計在預測期內複合年成長率最高

血管修復和重組領域預計在預測期內複合年成長率最高，因為它需要能夠承受血流壓力的堅固、耐用和生物相容性補片。這將推動補片材料的創新，並專注於血管應用的特定功能。此外，它還包括從動脈瘤治療到周邊動脈疾病的各種手術。特定應用需要不同類型的補丁，從而為不同的補丁技術創造了多樣化的市場。

比最大的地區

由於心臟疾病患病率上升、製藥公司大量存在、研發費用增加以及疝氣疾病發生率增加，預計北美將在預測期內佔據最大的市場佔有率。例如，根據美國7 月疾病管制與預防中心的資料，心臟病是美國的主要原因之一。冠心病是所有心臟病中最常見的心臟病，在美國約有2010萬20歲以上的成年人患有冠心病，推動了該地區的市場成長。

複合年成長率最高的地區：

醫療基礎設施的快速發展、微創手術的成長趨勢、心臟疾病盛行率的上升、醫療旅遊的增加、中國和印度等多個國家的經濟快速擴張、老年人口的增加以及慢性病負擔的增加。方面，預計亞太地區在預測期內將保持最高的複合年成長率，並預計在未來幾年內實現最快的成長率。此外，人們對先天性心臟疾病早期診斷、檢測和及時治療重要性的認知不斷提高，也正在推動市場的發展。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球心血管和軟組織修復貼片市場：按產品類型

  • 血管補片
  • 心臟貼片
  • 整形外科修復補片
  • 硬腦膜修補補片
  • 疝氣修補片
  • 乳房重建補片
  • 其他產品類型

第6章全球心血管和軟組織修復貼片市場：依材料類型

  • 生物補丁
    • 異種移植
    • 同種異體移植
  • 合成補丁
    • 聚四氟乙烯 (PTFE)
    • 聚酯纖維
    • 聚丙烯
    • 其他合成補丁

第7章全球心血管和軟組織修復貼片市場：按應用分類

  • 血管修復與重組
  • 動脈瘤修復
  • 心包修復術
  • 硬腦膜修復
  • 軟組織修復
  • 心臟修復
    • 先天性心臟疾病
    • 閥門維修
  • 其他用途

第8章全球心血管和軟組織修復貼片市場：按最終用戶分類

  • 日間手術中心 (ASC)
  • 醫院
  • 專科診所
  • 研究/學術機構
  • 其他最終用戶

第9章全球心血管和軟組織修復貼片市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司概況

  • Abbott
  • Admedus
  • Atriummed
  • B.Braun
  • Bard Peripheral Vascular Inc.
  • Baxter
  • CorMatrix
  • Cryolife, Inc.
  • Edwards Life Sciences Corporation
  • Glycar SA Pty Ltd.
  • Integra LifeSciences Corporation
  • LabCor
  • LeMaitre Vascular Inc.
  • Maverick Bioscience
  • Neovasc
  • Novomedics
  • Southern Lights Biomaterials
  • TEI Biosciences Inc.
  • Terumo Medical Corporation
  • WL Gore & Associates, Inc.
Product Code: SMRC26324

According to Stratistics MRC, the Global Cardiovascular & Soft Tissue Repair Patch Market is accounted for $5.0 billion in 2024 and is expected to reach $9.0 billion by 2030 growing at a CAGR of 10.1% during the forecast period. Cardiovascular and Soft Tissue Repair Patches are medical devices used in surgical procedures to repair damaged or weakened tissues in the cardiovascular system or soft tissues elsewhere in the body. These patches are typically made from biocompatible materials, such as synthetic polymers or biological tissues, that are compatible with the body's natural healing processes. In cardiovascular surgeries, these patches are commonly used to repair defects in the heart's walls, such as septal defects or congenital heart defects, or to reinforce weakened areas of blood vessels, such as aneurysms or arteriotomies.

According to the article published by PubMed Central in August 2021, a cross-sectional study was performed on 500 participants in Saudi Arabia, which showed that the prevalence of abdominal hernia was 38.8 percent and the participants in 18-25 years had less prevalence of 21.2 percent.

Market Dynamics:

Driver:

Rising prevalence of cardiovascular disease and soft tissue injuries

Cardiovascular diseases, including heart attacks and congenital heart defects, becoming increasingly common due to factors like aging populations, lifestyle changes, and genetic predispositions, there is a growing demand for effective surgical interventions. Similarly, the incidence of soft tissue injuries, such as hernias and abdominal wall defects, is on the rise due to factors like increased physical activity and trauma. This surge in medical conditions requiring surgical repair boosts the demand for advanced repair patches. These patches offer reliable solutions for reinforcing or replacing damaged tissues, enhancing surgical outcomes and patient recovery driving the markets growth.

Restraint:

High cost of procedures

Advanced medical devices often come with substantial costs due to the sophisticated materials and technologies involved in their development and manufacturing. Consequently, the overall expense of surgical procedures using these patches can be prohibitive for many patients, particularly those without adequate health insurance coverage or in regions with limited healthcare funding. Therefore, the financial challenges associated with these procedures hinder the widespread adoption and growth of the cardiovascular and soft tissue repair patch market.

Opportunity:

Advancements in material science and technology

Innovations in biocompatible materials, such as bioengineered tissues, synthetic polymers, and nanomaterials, have led to the development of more effective, durable, and versatile repair patches. These cutting-edge materials improve the patches' ability to integrate with natural tissues, reduce the risk of rejection, and enhance the overall healing process. In addition technological advancements have also enabled the creation of patches with specialized features, such as drug-eluting properties, which can deliver medications directly to the repair site to prevent infection and promote healing leading to increased adoption and expanded use of cardiovascular and soft tissue repair patches.

Threat:

Stringent regulatory requirements

Regulatory agencies, such as the FDA and EMA, impose rigorous standards for safety, efficacy, and quality, requiring extensive clinical testing and documentation. This leads to prolonged development timelines and increased costs for manufacturers, who must invest significant resources to meet these stringent criteria. As a result, stringent regulatory requirements can limit the availability of new and improved cardiovascular and soft tissue repair patches, hindering market growth and delaying patient access to cutting-edge treatments.

Covid-19 Impact

Initially, lockdowns and resource allocation towards COVID-19 cases led to a decline in elective surgeries, including those requiring repair patches. This caused a temporary dip in market growth. However, as healthcare systems adapted, procedures resumed, and the market recovered. The focus on hygiene might have also driven aseptic patch adoption. Overall, after a temporary setback, the market is expected to return to its pre-pandemic growth trajectory, fueled by the rising prevalence of cardiovascular diseases and advancements in patch technology.

The cardiac patches segment is expected to be the largest during the forecast period

The cardiac patches is expected to be the largest during the forecast period as cardiac patches are often used in minimally invasive heart surgeries. This minimally invasive approach is a major trend in cardiovascular treatments, and cardiac patches play a key role in facilitating it. As minimally invasive procedures become more prevalent, the demand for cardiac patches is expected to rise. Moreover, effective cardiac patches can promote tissue regeneration, improve heart function, and reduce complications. This translates to better patient outcomes, leading to a higher adoption rate by surgeons and increased demand for these patches.

The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period

The vascular repair & reconstruction segment is expected to have the highest CAGR during the forecast period because these procedures necessitate strong, durable, and biocompatible patches that can withstand the pressure of blood flow. This drives innovation in patch materials, with a focus on functionalities specifically suited for vascular applications. Further it also encompasses various procedures, from treating aneurysms to peripheral artery disease. The need for different patch types based on the specific application creates a diversified market for various patch technologies.

Region with largest share:

North America is projected to hold the largest market share during the forecast period due to the rising prevalence of cardiac diseases, the presence of a large number of pharmaceutical companies, growing research and development expenditure, and increasing incidences of hernia disorders. For instance, according to data from the Centers for Disease Control and Prevention in July 2022, heart disease is one of the leading causes of death in the United States. Among all the heart diseases coronary heart disease is the most common type of heart disease and about 20.1 million adults age 20 and older have coronary heart disease in the United States drives the growth of the market in this region.

Region with highest CAGR:

Asia Pacific is projected to hold the highest CAGR over the forecast period owing to rapid developments in healthcare infrastructure, growing trends of minimally invasive surgical procedures, rising incidence of cardiac disease, increasing medical tourism, rapid economic expansion in several countries such as China and India, rising geriatric population, and increasing burden of chronic disorders, Asia Pacific is expected to register the fastest growing rate in the coming years. Additionally raising awareness about the importance of early diagnosis and detection of congenital cardiac disorders, as well as quick treatment propels the market.

Key players in the market

Some of the key players in Cardiovascular & Soft Tissue Repair Patch market include Abbott, Admedus, Atriummed, B.Braun, Bard Peripheral Vascular Inc., Baxter, CorMatrix, Cryolife, Inc., Edwards Life Sciences Corporation, Glycar SA Pty Ltd., Integra LifeSciences Corporation, LabCor, LeMaitre Vascular Inc., Maverick Bioscience, Neovasc, Novomedics, Southern Lights Biomaterials, TEI Biosciences Inc., Terumo Medical Corporation and W.L. Gore & Associates, Inc.

Key Developments:

In April 2024, Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit(TM) BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK).

In April 2024, Baxter Announces Mission and Logo for Proposed Kidney Care Company Vantive. The Vantive mission, Extending Lives, Expanding Possibilities, will guide and inspire the proposed company, which will focus on vital organ therapies for acute and chronic kidney diseases and beyond.

In March 2024, Abbott, and the Real Madrid Foundation announced the extension of their partnership through Real Madrid's 2026-27 season. Abbott will remain Global Health Sciences and Nutrition Partner of Real Madrid Football Club and Global Partner of the Real Madrid Foundation.

Product Types Covered:

  • Vascular Patches
  • Cardiac Patches
  • Orthopedic Repair Patches
  • Dural Repair Patches
  • Hernia Repair Patches
  • Breast Reconstruction Patches
  • Other Product Types

Material Types Covered:

  • Biologic Patches
  • Synthetic Patches

Applications Covered:

  • Vascular Repair & Reconstruction
  • Aneurysm Repair
  • Pericardial Repair
  • Dural Repair
  • Soft Tissue Repair
  • Cardiac Repair
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers (ASCs)
  • Hospitals
  • Specialty Clinics
  • Research & Academic Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Cardiovascular & Soft Tissue Repair Patch Market, By Product Type

  • 5.1 Introduction
  • 5.2 Vascular Patches
  • 5.3 Cardiac Patches
  • 5.4 Orthopedic Repair Patches
  • 5.5 Dural Repair Patches
  • 5.6 Hernia Repair Patches
  • 5.7 Breast Reconstruction Patches
  • 5.8 Other Product Types

6 Global Cardiovascular & Soft Tissue Repair Patch Market, By Material Type

  • 6.1 Introduction
  • 6.2 Biologic Patches
    • 6.2.1 Xenografts
    • 6.2.2 Allografts
  • 6.3 Synthetic Patches
    • 6.3.1 Polytetrafluoroethylene (PTFE)
    • 6.3.2 Polyester
    • 6.3.3 Polypropylene
    • 6.3.4 Other Synthetic Patches

7 Global Cardiovascular & Soft Tissue Repair Patch Market, By Application

  • 7.1 Introduction
  • 7.2 Vascular Repair & Reconstruction
  • 7.3 Aneurysm Repair
  • 7.4 Pericardial Repair
  • 7.5 Dural Repair
  • 7.6 Soft Tissue Repair
  • 7.7 Cardiac Repair
    • 7.7.1 Congenital Heart Defects
    • 7.7.2 Valve Repair
  • 7.8 Other Applications

8 Global Cardiovascular & Soft Tissue Repair Patch Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers (ASCs)
  • 8.3 Hospitals
  • 8.4 Specialty Clinics
  • 8.5 Research & Academic Institutions
  • 8.6 Other End Users

9 Global Cardiovascular & Soft Tissue Repair Patch Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott
  • 11.2 Admedus
  • 11.3 Atriummed
  • 11.4 B.Braun
  • 11.5 Bard Peripheral Vascular Inc.
  • 11.6 Baxter
  • 11.7 CorMatrix
  • 11.8 Cryolife, Inc.
  • 11.9 Edwards Life Sciences Corporation
  • 11.10 Glycar SA Pty Ltd.
  • 11.11 Integra LifeSciences Corporation
  • 11.12 LabCor
  • 11.13 LeMaitre Vascular Inc.
  • 11.14 Maverick Bioscience
  • 11.15 Neovasc
  • 11.16 Novomedics
  • 11.17 Southern Lights Biomaterials
  • 11.18 TEI Biosciences Inc.
  • 11.19 Terumo Medical Corporation
  • 11.20 W.L. Gore & Associates, Inc.

List of Tables

  • Table 1 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Product Type (2021-2030) ($MN)
  • Table 3 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Patches (2021-2030) ($MN)
  • Table 4 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Patches (2021-2030) ($MN)
  • Table 5 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Orthopedic Repair Patches (2021-2030) ($MN)
  • Table 6 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair Patches (2021-2030) ($MN)
  • Table 7 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hernia Repair Patches (2021-2030) ($MN)
  • Table 8 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Breast Reconstruction Patches (2021-2030) ($MN)
  • Table 9 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Product Types (2021-2030) ($MN)
  • Table 10 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Material Type (2021-2030) ($MN)
  • Table 11 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Biologic Patches (2021-2030) ($MN)
  • Table 12 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Xenografts (2021-2030) ($MN)
  • Table 13 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Allografts (2021-2030) ($MN)
  • Table 14 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Synthetic Patches (2021-2030) ($MN)
  • Table 15 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polytetrafluoroethylene (PTFE) (2021-2030) ($MN)
  • Table 16 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polyester (2021-2030) ($MN)
  • Table 17 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Polypropylene (2021-2030) ($MN)
  • Table 18 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Synthetic Patches (2021-2030) ($MN)
  • Table 19 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Application (2021-2030) ($MN)
  • Table 20 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Vascular Repair & Reconstruction (2021-2030) ($MN)
  • Table 21 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Aneurysm Repair (2021-2030) ($MN)
  • Table 22 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Pericardial Repair (2021-2030) ($MN)
  • Table 23 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Dural Repair (2021-2030) ($MN)
  • Table 24 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Soft Tissue Repair (2021-2030) ($MN)
  • Table 25 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Cardiac Repair (2021-2030) ($MN)
  • Table 26 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Congenital Heart Defects (2021-2030) ($MN)
  • Table 27 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Valve Repair (2021-2030) ($MN)
  • Table 28 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By End User (2021-2030) ($MN)
  • Table 30 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Ambulatory Surgical Centers (ASCs) (2021-2030) ($MN)
  • Table 31 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 32 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 33 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Research & Academic Institutions (2021-2030) ($MN)
  • Table 34 Global Cardiovascular & Soft Tissue Repair Patch Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.